key: cord-0965621-8snlni7x
authors: Ribeiro, Ruan C.B.; de Marins, Daniel B.; Di Leo, Iris; da Silva Gomes, Luana; de Moraes, Matheus G.; Abbadi, Bruno L.; Villela, Anne D.; da Silva, Wellington F.; da Silva, Luiz Cláudio R.P.; Machado, Pablo; Bizarro, Cristiano Valim; Basso, Luiz Augusto; Cristina de Moraes, Marcela; Ferreira, Vitor F.; da Silva, Fernando de C.; Nascimento, Vanessa
title: Anti-tubercular Profile of New Selenium-Menadione Conjugates against Mycobacterium tuberculosis H37Rv (ATCC 27294) Strain and Multidrug-Resistant Clinical Isolates
date: 2020-09-23
journal: Eur J Med Chem
DOI: 10.1016/j.ejmech.2020.112859
sha: 6918c10814e703ffeee070428c3a9334fbafe5e2
doc_id: 965621
cord_uid: 8snlni7x

Tuberculosis (TB) is one of the most fatal diseases and is responsible for the infection of millions of people around the world. Most recently, scientific frontiers have been engaged to develop new drugs that can overcome drug-resistant TB. Following this direction, using a designed scaffold based on the combination of two separate pharmacophoric groups, a series of menadione-derived selenoesters was developed with good yields. All products were evaluated for their in vitro activity against Mycobacterium tuberculosis H37Rv and attractive results were observed, especially for the compounds 8a, 8c and 8f (MICs 2.1, 8.0 and 8.1 μM, respectively). In addition, 8a, 8c and 8f demonstrated potent in vitro activity against multidrug-resistant clinical isolates (CDCT-16 and CDCT-27) with promising MIC values ranging from 0.8 to 3.1 μM. Importantly, compounds 8a and 8c were found to be non-toxic against the Vero cell line. The SI value of 8a (>23.8) was found to be comparable to that of isoniazid (>22.7), which suggests the possibility of carrying out advanced studies on this derivative. Therefore, these menadione-derived selenoesters obtained as hybrid compounds represent promising new anti-tubercular agents to overcome TB multidrug resistance.

Tuberculosis (TB) is a major public health concern worldwide representing the 64 principal cause of death from a single infectious agent, Mycobacterium tuberculosis. 65 Each year, approximately 10 million people become ill with TB, with the prevailing 66 incidence in Southeast Asia and Africa. The risk of developing TB is high, considering 67 an estimated 1.7 billion people globally infected with these mycobacteria [1, 2] . In 2018, 68 7 million of new cases and 11.1 million of the estimated incident cases were reported. for TB and are a major public health concern. MDR and XDR strains are often 85 associated with low cure and high mortality rates [1]. In the last three years, synthetic methodologies to coupling selenium groups 134 involving direct selenilation of the quinone ring have been described through Rh-135 catalyzed C-H phenylselenation, as shown in Fig. 2 . For example, (phenylseleno)-phthalimide or phenyl hypochloroselenoites as an electrophile, the C-2 137 selenation of naphthoquinone can be performed, as well as the Rh-catalyzed selenation 138 of benzoquinone ( Fig. 2A ) [37] [38] [39] . 139 We herein report on the synthesis of a new series of naphthoquinone derivatives The reagents were purchased from Sigma-Aldrich Brazil and were used without 154 further purification. Column chromatography was performed with silica gel 60 (Merck 155 70-230 mesh). Analytical thin layer chromatography was performed with silica gel 156 plates (Merck, TLC silica gel 60 F 254 ), and the plates were visualized using UV light.

coupling constants (J) are reported in hertz and refer to apparent peak multiplicities.

High-resolution mass spectra (HRMS) were recorded on a MICROMASS Q-TOF mass 168 spectrometer (Waters) and the deviation of the measured mass from the theoretical mass 169 (∆) was inserted in ppm. Intrinsic Phasing and refinement package using Least Squares Methods with the 175 SHELX programs [40] . Non-hydrogen atoms were refined with anisotropic 176 displacement parameters, and the hydrogen atoms were positioned geometrically using 177 the riding model. Molecular graphics draw using SHELXL [41] .

The protocol for preparing 2-(chloromethyl)-3-methylnaphthalene-1,4-dione (9) 179 was performed as described by Ferreira and cols. [42] . : 193.32, 183.92, 183.27, 196 143. 53, 143.11, 137.62, 134.30, 133.96, 133.81, 131.55, 131.20, 129.22, 126.77, 197 125. 91, 125.77, 19.81, 12.59 Se-( (3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl) 43, 185.04, 184.42, 145.15, 144.47, 144.25, 136.07, 205 133.84, 133.70, 132.40, 132.10, 129.75, 127.58, 126.66, 126.57, 21.92, 20.14, 13.22 51, 185.10, 184.49, 151.35, 144.53, 223 144. 28, 133.88, 132.43, 132.13, 131.94, 128.83, 128.62, 127.71, 126.70, 126.61, 29.23, 224 20.16, 15.29, 13.25 CDCl 3 ) δ ppm: 200.92, 184.70, 183.99, 144.22, 143.78, 133.60, 133.47, 132.12, 131.81, 257 126. 39, 126.30, 47.25, 27.45, 21.98, 19.79, 13.68, 12. Metabolically active cells were assessed using the MTT reduction colorimetric 310 assay, as previously reported by Mosmann (1983) [45] and Alley (1988) [46] . Cells multidrug resistance (Fig. 3) . This selenofunctionalization of menadione is described 

The synthetic approach used to obtain selenium-containing menadione 345 derivatives 8a-i initially provided some synthetic steps described in the literature [42] 346 and was based on a two-step pathway entailing the use of commercial menadione (7).

The synthetic route started with the first reaction of the insertion of the -CH 2 Cl group in 348 menadione, in excellent yield (95 %), through the reaction with formaldehyde, glacial 349 acetic acid and dry hydrogen chloride, obtaining 2-(chloromethyl)-3-350 methylnaphthalene-1,4-dione (7) (Fig. 3) . 351 Then, we promoted the selenofuncionalization of 9 through the reaction with the 352 respective selenocarboxylate that was generated in situ from benzoyl chloride and Se 0 353 (Fig. 3) . Using different acyl chlorides and benzoylchlorides, a series of menadione-354 derived selenoesters in moderate to good yields ranged between 24-75 % was obtained, 355 as reported in Fig. 3 .

For example, compound 8b, with p-methylbenzoyl chloride, was obtained in 58 357 % yield, while the best yield was represented by compound 8a with 75 % (Fig. 3) .

Exchanging the aromatic for aliphatic selenocarboxylate led to a decrease in the yield, 359 as shown in Fig. 3 . Additionally, we found that a change in the electron-donating group 360 in the aromatic ring to an electron withdrawer group did not produce significant 361 variation in the product yield. The synthetic approach chosen shows that overall returns 362 ranged from 23 to 71 % . Fig. 3 . Synthesis of menadione-derived selenoesters 8a-i.

The structure of all products synthetized was confirmed by 1 H and 13 C nuclear permeate through M. tuberculosis cell wall [55] . As reported in Table 2 ClogP values consistent with the classic rule of five [56] . In addition, the number of 462 hydrogen bonds donors (< 5) and hydrogen bonds acceptors (< 10) as well as the 463 molecular mass (< 500 D) were also respected, suggesting that these molecules may 464 have adequate bioavailability when orally administered. between toxicity in Vero cells, isolated renal tissue and nephrotoxicity in rats [57] . biological activity and toxicity, suggest the continuation of this study for in vivo tests, to phenomenon of resistance to multiple TB drugs. The next steps to understand the mechanism of action and to determine the molecular target(s) of the selenium-506 containing naphthoquinones will include the selection of spontaneous mutants, the 507 whole-genome sequencing of the obtained mutants, and the use of genetic approaches to 508 validate the gene(s) involved in the mechanism of action and resistance. Besides, 509 considering that ebselen is known to bind and inhibit the antigen 85 (Ag85) complex 510 activity, which is involved in the biosynthesis of trehalose dimycolate and 511 mycolylarabinogalactan, both essential components of the mycomembrane [28] , 512 attempts will be made to evaluate the capacity of our compounds to inhibit in vitro the 

Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment

Advances in the development of new tuberculosis drugs and treatment regimens

New agents for the treatment of drugresistant Mycobacterium tuberculosis

Multidrug-resistant tuberculosis around the world: what progress has been made?

Totally drug-resistant tuberculosis and adjunct therapies

The antifungal activity of naphthoquinones: an integrative review

New family of antimicrobial agents derived from 1,4-naphthoquinone

Beyond topoisomerase inhibition: antitumor 1,4-naphthoquinones as potential inhibitors of human monoamine oxidase

eIF2 kinases mediate β-lapachone toxicity in yeast and human cancer cells

Naphthoquinones: A continuing source for discovery of therapeutic antineoplastic agents

Synthesis and evaluation of the cytotoxic activity of furanaphthoquinones tethered to 1H-1,2,3-triazoles in Caco-2, Calu-3, MDA-MB231 cells

Novel menadione hybrids: Synthesis, anticancer activity, and cell-based studies

Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against panresistant first-line drugs Mycobacterium tuberculosis strains

A structure-activity relationship study of naphthoquinone derivatives as antitubercular agents using molecular modeling techniques

Catalytic application of selenium and tellurium compounds as glutathione peroxidase enzyme mimetics

Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds

-Benzisoselenazol-3(2H)-one derivatives as a new class of bacterial urease inhibitors

In vitro antifungal evaluation and structure-activity relationship of diphenyl diselenide and synthetic analogues

NCp7: targeting a multitask protein for next-generation anti-HIV drug development part 2. Noncovalent inhibitors and nucleic acid binders

Molecular descriptors calculation as a tool in the analysis of the antileishmanial activity achieved by two series of diselenide derivatives. An insight into its potential action mechanism

Functional mimics of glutathione peroxidase: bioinspired synthetic antioxidants

Azaanalogues of ebselen as antimicrobial and antiviral agents: synthesis and properties

Mechanism of inhibition of Mycobacterium tuberculosis J o u r n a l P r e -p r o o f antigen 85 by ebselen

Ebselen and analogs as inhibitors of Bacillus anthracis thioredoxin reductase and bactericidal antibacterials targeting Bacillus species, Staphylococcus aureus and Mycobacterium tuberculosis

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Synthesis and antitumor activity of selenium-containing quinone-based triazoles possessing two redox centres, and their mechanistic insights

New selenenylation Method. Synthesis of selenonaphthoquinones and selenoquinolinequinones mediated by phenyl selenide ion

Multifunctional redox catalysts as selective enhancers of oxidative

Exploring synthetic avenues for the effective synthesis of selenium-and tellurium-containing multifunctional redox agents

Synthesis and selective anticancer activity of organochalcogen based redox catalysts

Selenium-and tellurium-containing multifunctional redox agents as biochemical redox modulators with selective cytotoxicity

Rh-catalyzed reactions of 1,4-benzoquinones with electrophiles: C-H iodination, bromination, and phenylselenation

Rhodium-catalyzed C-H bond activation for the synthesis of quinonoid compounds: Significant Anti-Trypanosoma cruzi activities and electrochemical studies of functionalized quinines

Synthesis of seleniumquinone hybrid compounds with potential antitumor activity via Rh-catalyzed C-H bond activation and click reactions

SHELXT-Integrated space-group and crystal-structure determination

OLEX 2: a complete structure solution, refinement and analysis program

The Diels-Alder reaction with O-2, 3-dimethylene-1, 4-naphthoquinone: a useful intermediate for the synthesis of the B ring of anthracyclinones

New insights into the SAR and drug combination synergy of 2

Mycobacterium tuberculosis

Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agents

Rapid colorimetric assay for cellular growth and survival: application to proliferation and citotoxicity assays

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay

Synthesis and evaluation of dihydropyrimidinone-derived selenoesters as multi-targeted directed compounds against Alzheimer's disease

Air-stable binuclear Titanium(IV) salophen perfluorobutanesulfonate with zinc power catalytic system and its application to C-S and C-Se bond formation

Side-chain alkylthiolation of methyl-1,4-naphthoquinones

Discovery of novel naphthoquinone derivatives as inhibitors of the tumor cell specific M2 isoform of pyruvate kinase

Tables of bond lengths determined by X-ray and neutron diffraction. Part 1. Bond lengths in organic compounds

SHELXL-97. Program for crystal structures analysis

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline

Revisiting activation of and mechanism of resistance to compound IQG-607 in Mycobacterium tuberculosis

Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

In vitro and in vivo effects of phenolic antioxidants against cisplatin-induced nephrotoxicity